Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis, Neoplasm”

22,699 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22,699 results

Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Testing effectiveness (Phase 2)Study completedNCT02544997
What this trial is testing

A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway

Who this might be right for
Metastatic Breast Cancer
Samsung Medical Center 5
Early research (Phase 1)Study completedNCT02262910
What this trial is testing

Study of ES414 in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Aptevo Therapeutics 35
Not applicableStudy completedNCT07115810
What this trial is testing

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

Who this might be right for
Differentiated Thyroid Cancer
King Faisal Specialist Hospital & Research Center 178
Testing effectiveness (Phase 2)Study completedNCT02259582
What this trial is testing

Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
OncoMed Pharmaceuticals, Inc. 82
Post-approval studies (Phase 4)Not Yet RecruitingNCT06245824
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Not applicableActive Not RecruitingNCT05844761
What this trial is testing

Real-time Motion Management During Prostate and Lung Radiotherapy

Who this might be right for
Cancer of LungLung MetastasisCancer of Prostate
Region Skane 132
Testing effectiveness (Phase 2)UnknownNCT02596373
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer

Who this might be right for
Advanced Recurrent or Metastatic Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT04645069
What this trial is testing

ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 58
Testing effectiveness (Phase 2)UnknownNCT00353717
What this trial is testing

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Who this might be right for
Breast Neoplasms
Hadassah Medical Organization 25
Testing effectiveness (Phase 2)Study completedNCT02138617
What this trial is testing

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
UNC Lineberger Comprehensive Cancer Center 100
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Large-scale testing (Phase 3)Looking for participantsNCT02582697
What this trial is testing

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Who this might be right for
Germ Cell Tumor
University of Sydney 500
Not applicableStudy completedNCT01227213
What this trial is testing

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
HypertensionRenal FunctionInsulin Sensitivity+1 more
Radboud University Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT05371223
What this trial is testing

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases

Who this might be right for
Peritoneal CarcinomatosisPancreas Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Early research (Phase 1)Ended earlyNCT06523803
What this trial is testing

ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers

Who this might be right for
Mesothelin-expressing Advanced Cancers
Zymeworks BC Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06176261
What this trial is testing

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Who this might be right for
Breast CancerBreast Cancer FemaleMetastatic Triple-Negative Breast Carcinoma+4 more
Nancy Lin, MD 58
Next Page